Filing Details
- Accession Number:
- 0001209191-21-053523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-26 17:54:36
- Reporting Period:
- 2021-08-25
- Accepted Time:
- 2021-08-26 17:54:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1637715 | Reneo Pharmaceuticals Inc. | RPHM | Pharmaceutical Preparations (2834) | 472309515 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1855115 | R. Vineet Jindal | C/O Reneo Pharmaceuticals, Inc. 18575 Jamboree Road, Suite 275-S Irvine CA 92612 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-25 | 5,000 | $7.44 | 5,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.